在患有重度抑郁症患者的左门中出现多巴胺功能障碍
Antonio Maria D'Onofrio1, Daniele Antonio Pizzuto2, Rana Batir1
1Department of Neuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Journal of affective disorders
|April 18, 2024
概括
多巴胺功能受损与抑郁症症状有关. 这项研究发现,左骨中多巴胺载体可用性的减少与严重抑郁症患者的抑郁,焦虑,无情感和精神运动迟缓的增加有关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 放射学 放射学是一门学科.
背景情况:
- 多巴胺传输障碍是抑郁症和相关症状 (如无情感和精神运动迟缓) 的关键神经生物学因素.
- 了解多巴胺缺乏和主要抑郁障碍 (MDD) 心理病理学之间的特定关系对于开发向治疗至关重要.
研究的目的:
- 研究在被诊断为MDD的患者中,条状多巴胺转运体 (DAT) 可用性和特定的精神病理维度之间的关联.
- 通过使用先进的成像技术,探索抑郁症谱症状的神经生物学基础.
主要方法:
- 从1106个123I-FP-CIT SPECT扫描数据库中对121名MDD患者 (67名女性,54名男性) 的回顾性分析.
- 使用SPECT成像和与心理测量评估的相关性,包括汉密尔顿抑郁评分表,汉密尔顿焦虑评分表,斯奈思汉密尔顿快乐评分表和抑郁迟缓评分表等.
主要成果:
- 观察到左门的DAT可用性与抑郁症 (p=0.007),焦虑症 (p=0.035),无情感 (p=0.028) 和精神运动迟缓 (p=0.014) 的水平之间存在显著的负相关性.
- 患有严重抑郁症 (p=0.027) 和显著的精神运动迟缓 (p=0.048) 的患者在左门中表现出较低的DAT可用性.
结论:
- 这项研究的样本规模很大,强调了多巴胺功能障碍在MDD中的关键作用.
- 在左门中减少的DAT可用性与MDD患者的抑郁症,焦虑症,无情感和精神运动迟缓的增加特别相关.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:27Depressive Disorders: MDD and Dysthymia
112
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
112
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
01:18Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242
01:21G-protein Coupled Receptors
118.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.6K